Publications by authors named "Johan Jansson"

Claim this Profile
P
Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma.
Ryan J Sullivan, Katy K Tsai, Anna C Pavlick, Elizabeth I Buchbinder, Sanjiv S Agarwala, Johan Jansson

J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study.
Tatsunori Goto, Hiroshi Okamura, Takashi Ikeda, Yasuo Mori, Souichi Shiratori, Johan Jansson

Int J Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical considerations of promising zone design for interim sample size Re-estimation: An application to GRAPHITE for graft vs host disease.
Jingjing Chen, Yohei Takanami, Johan Jansson, Guillermo Rossiter

Contemp Clin Trials· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic modeling of vedolizumab for graft-versus-host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant.
Timothy Waterhouse, Kyle Baron, Westley Eure, Chunlin Chen, Nathanael L Dirks, Johan Jansson

Pharmacol Res Perspect· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial.
Yi-Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy, Johan Jansson

Nat Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.
Yngvar Fløisand, Mark A Schroeder, Patrice Chevallier, Dominik Selleslag, Steven Devine, Johan Jansson

Bone Marrow Transplant· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portable simulation framework for diffusion MRI.
Van-Dang Nguyen, Massimiliano Leoni, Tamara Dancheva, Johan Jansson, Johan Hoffman

J Magn Reson· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Yi-Bin Chen, Nirav N Shah, Anne S Renteria, Corey Cutler, Johan Jansson

Blood Adv· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A computational model of open-irrigated radiofrequency catheter ablation accounting for mechanical properties of the cardiac tissue.
Argyrios Petras, Massimiliano Leoni, Jose M Guerra, Johan Jansson, Luca Gerardo-Giorda

Int J Numer Method Biomed Eng· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion MRI simulation in thin-layer and thin-tube media using a discretization on manifolds.
Van-Dang Nguyen, Johan Jansson, Hoang Trong An Tran, Johan Hoffman, Jing-Rebecca Li

J Magn Reson· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nurses' Perspectives on In-Home Monitoring of Elderlies's Motion Pattern.
Joakim Klemets, Jukka Määttälä, Johan Jansson, Ismo Hakala

Stud Health Technol Inform· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D Fluid-Structure Interaction Simulation of Aortic Valves Using a Unified Continuum ALE FEM Model.
Jeannette H Spühler, Johan Jansson, Niclas Jansson, Johan Hoffman

Front Physiol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive unified continuum FEM modeling of a 3D FSI benchmark problem.
Johan Jansson, Niyazi Cem Degirmenci, Johan Hoffman

Int J Numer Method Biomed Eng· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
Maria Sundberg, Helle Bogetofte, Tristan Lawson, Johan Jansson, Gaynor Smith

Stem Cells· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential.
Safiehkhatoon Moshkani, Igor I Kuzin, Funmilola Adewale, Johan Jansson, Iñaki Sanz

J Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects.
Johan Jansson, Yu-Chiao Hsu, Igor I Kuzin, Andrew Campbell, Craig A Mullen

Leuk Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of B cell immune responses to acute lymphoblastic leukemia in murine allogeneic hematopoietic stem cell transplantation recipients treated with donor lymphocyte infusion and/or vaccination.
Craig A Mullen, Andrew Campbell, Olena Tkachenko, Johan Jansson, Yu-Chiao Hsu

Biol Blood Marrow Transplant· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.
Jessica C Shand, Johan Jansson, Yu-Chiao Hsu, Andrew Campbell, Craig A Mullen

Cancer Immunol Immunother· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.
Faith M Young, Andrew Campbell, Kris Lambert Emo, Johan Jansson, Pin-Yi Wang

Biol Blood Marrow Transplant· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis